Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2009-05-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypothesis is to find the same biochemical marker for orange juice as we already found in a preceding nutritional studies where participants recorded orange consumption.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Citrus Products on Cardiovascular Health
NCT03611114
Using Untargeted Metabolomics to Identify Urinary Biomarkers of Onion Intake
NCT05133986
The Effects of Orange Juice on Insulin Sensitivity and Plasma Lipids
NCT01201603
The Orange Juice and Cardiovascular Disease Study
NCT02195934
Postprandial Response of Fresh-squeezed and Processed Orange Juice of Lean and Obese Subjects
NCT03032120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Days 1-3 will be on open diet but with dietary restrictions (no alcohol, cheese, fruits, ethnic foods such as Chinese and Indian food, grain legumes such as beans, lentils, peas and peanuts, and all kinds of sprouts (such as cress or alfalfa)). On day 2 a glass of orange juice (200ml) will be consumed in addition to the open diet. Urine collection will continue and stop on day 4 at 10 am.
During the study to minimise variation in biomarker excretion due to other beverages the participants beverage intake will be restricted to water and coffee.
All urine samples will then be analysed using high resolution NMR spectroscopy and mass spectrometry. Mathematical data analyses as well as the visual examinations of the NMR spectra will also be carried out to validate the presence of citrus fruit biomarkers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orange Juice
1 glass (=200mL) of orange juice
orange juice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
orange juice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male/female
* aged 18-45 years
* non-smoker
* BMI 18-25 kg/m2
Exclusion Criteria
* regular food supplements intake
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Heinzmann SS, Brown IJ, Chan Q, Bictash M, Dumas ME, Kochhar S, Stamler J, Holmes E, Elliott P, Nicholson JK. Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumption. Am J Clin Nutr. 2010 Aug;92(2):436-43. doi: 10.3945/ajcn.2010.29672. Epub 2010 Jun 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
557-ICL-649
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.